Amedisys, Inc. (NASDAQ:AMED) Shares Sold by New York State Teachers Retirement System

New York State Teachers Retirement System lessened its stake in Amedisys, Inc. (NASDAQ:AMED) by 6.7% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 26,276 shares of the health services provider’s stock after selling 1,900 shares during the quarter. New York State Teachers Retirement System owned 0.08% of Amedisys worth $2,386,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Westchester Capital Management LLC increased its position in shares of Amedisys by 9.5% in the third quarter. Westchester Capital Management LLC now owns 1,118,802 shares of the health services provider’s stock valued at $107,976,000 after buying an additional 97,476 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Amedisys by 1.3% during the third quarter. Geode Capital Management LLC now owns 567,105 shares of the health services provider’s stock worth $54,746,000 after purchasing an additional 7,071 shares during the last quarter. Pacer Advisors Inc. grew its holdings in Amedisys by 11,621.9% in the 4th quarter. Pacer Advisors Inc. now owns 558,197 shares of the health services provider’s stock valued at $50,679,000 after buying an additional 553,435 shares during the period. Calamos Advisors LLC increased its position in Amedisys by 22.7% during the fourth quarter. Calamos Advisors LLC now owns 487,444 shares of the health services provider’s stock worth $44,255,000 after purchasing an additional 90,097 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its holdings in Amedisys by 2.7% in the third quarter. Charles Schwab Investment Management Inc. now owns 346,082 shares of the health services provider’s stock valued at $33,400,000 after acquiring an additional 9,004 shares during the last quarter. 94.36% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Stephens reissued an “equal weight” rating and issued a $101.00 price objective on shares of Amedisys in a research report on Wednesday, February 12th. Five analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, Amedisys currently has an average rating of “Hold” and a consensus price target of $100.75.

Amedisys Stock Down 0.7 %

NASDAQ:AMED opened at $90.43 on Friday. The firm has a market capitalization of $2.96 billion, a PE ratio of 35.88, a price-to-earnings-growth ratio of 1.80 and a beta of 0.73. Amedisys, Inc. has a 52 week low of $82.15 and a 52 week high of $98.95. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.05. The stock has a 50 day moving average of $90.74 and a 200-day moving average of $93.40.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.